About Robert Rabalais
Form D filings for Aviv Pharma in 2023 list Robert Rabalais as director.
Robert Rabalais first appears on SEC filings in 2023.
Experience
This experience comes from SEC filings. The years are when the filings name Robert Rabalais in the role, so the role may have started earlier or lasted longer.
Aviv Pharma Inc.
Director
2023 · Reno, NV
Develops and commercializes specialty and generic medicines for providers and patients.
Key Colleagues at Startups
The people Robert Rabalais works with at each company, as listed on that company's latest Form D.
Aviv Pharma Inc. · Form D, Dec 28, 2023
JG
Jeffrey Glazer
Executive officer and director
RH
Ricardo Hungria
Director
PE
Philip Epstein
Chairman
JR
Jeffrey Rosenberg
Director